Ce matrix metalloproteinase 13 through transcriptional activation of NFkappaB and p38 MAP kinase in articular chondrocytes. J Biol Chem 2006, 281(26):179527960. 19. Brzusek D, Petron D: Treating knee osteoarthritis with intra-articular hyaluronans. Existing med res opinion 2008, 24(12):3307322. 20. Takahashi K, Goomer RS, Harwood F, Kubo T, Hirasawa Y, Amiel D: The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta(IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the improvement of osteoarthritis. Osteoarthr cartil OARS Osteoarthr Res Soc 1999, 7(2):18290. 21. Yoshioka M, Shimizu C, Harwood FL, Coutts RD, Amiel D: The effects of hyaluronan during the improvement of osteoarthritis. Osteoarthr cartil OARS Osteoarthr Res Soc 1997, five(4):25160. 22. Kawai N, Tanaka E, Takata T, Miyauchi M, Tanaka M, Todoh M, van Eijden T, Tanne K: Influence of additive hyaluronic acid around the lubricating capability inside the temporomandibular joint.Methoprene J biomed mat res Part A 2004, 70(1):14953. 23. Kawano T, Miura H, Mawatari T, Moro-Oka T, Nakanishi Y, Higaki H, Iwamoto Y: Mechanical effects from the intraarticular administration of higher molecular weight hyaluronic acid plus phospholipid on synovial joint lubrication and prevention of articular cartilage degeneration in experimental osteoarthritis. Arthritis rheumatism 2003, 48(7):1923929. 24. Wobig M, Bach G, Beks P, Dickhut A, Runzheimer J, Schwieger G, Vetter G, Balazs E: The function of elastoviscosity within the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 in addition to a lower-molecular-weight hyaluronan. Clin Ther 1999, 21(9):1549562. 25. Larsen NE, Dursema HD, Pollak CT, Skrabut EM: Clearance kinetics of a hylan-based viscosupplement after intra-articular and intravenous administration in animal models. J biomed mat res Part B Applied biomat 2012, 100B:45762. 26. Brown TJ, Laurent UB, Fraser JR: Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan in the knee joint of the rabbit.Lactoferrin Exp Physiol 1991, 76(1):12534. 27. Miyazaki T, Yomota C, Okada S: Improvement and release characterization of hyaluronan-doxycycline gels primarily based on metal coordination. J Contr Release Off J Contr Release Soc 2001, 76(3):33747. 28. Gomis A, Miralles A, Schmidt RF, Belmonte C: Nociceptive nerve activity in an experimental model of knee joint osteoarthritis on the guinea pig: effect of intra-articular hyaluronan application. Pain 2007, 130(1):12636.PMID:24513027 29. Pozo MA, Balazs EA, Belmonte C: Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative. Experiment brain Res Experiment Hirnforschung Experiment cerebr 1997, 116(1):3. 30. Vincent HK, Montero C, Conrad BP, Horodyski M, Connelly J, Martenson M, Seay AN, Vincent KR: “Functional discomfort,” functional outcomes, and excellent of life following hyaluronic acid intra-articular injection for knee osteoarthritis. PM R J Injury Funct Rehab 2013. doi:10.1016/j. pmrj.2013.01.004. 31. Oka H, Akune T, Muraki S, Tanaka S, Kawaguchi H, Nakamura K, Yoshimura N: The mid-term efficacy of intra-articular hyaluronic acid injections on joint structure: a nested case handle study. Contemporary Rheumatol Japan Rheumatism Assoc 2012. doi:ten.1007/s10165-012-0725-7.Lu et al. BMC Veterinary Research 2013, 9:68 http://www.biomedcentral/1746-6148/9/Page 12 of32. Li P, Raitcheva D, Hawes M, Moran N, Yu X, Wang F, Matthews GL: Hylan GF 20 maintains cartilage integr.